Viridian Therapeutics, Inc. (VRDN)
13.90
-4.94
(-26.22%)
USD |
NASDAQ |
Apr 06, 16:00
13.88
-0.02
(-0.14%)
After-Hours: 07:25
Viridian Therapeutics SG&A Expense (TTM) : 95.31M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 4.185M |
| Boston Scientific Corp. | 6.888B |
| Plus Therapeutics, Inc. | 12.13M |
| Nutriband, Inc. | 7.831M |
| Immunovant, Inc. | 79.15M |